2024 Symposium Abstracts: Innovative Therapies for Neuroendocrine Tumors

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/08/77/ed/0877eda4-cbb1-bace-3644-e73fb7aced4f/mza_1512576652754283542.jpeg/600x600bb.jpg

NETCast

Podcasting4Associations

37 episodes

2 months ago

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more.

Visit us at

All content for NETCast is the property of Podcasting4Associations and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Visit us at

2024 Symposium Abstracts: Innovative Therapies for Neuroendocrine Tumors - Recorded November 20th, 2024

NETCast

18 minutes 15 seconds

10 months ago

2024 Symposium Abstracts: Innovative Therapies for Neuroendocrine Tumors - Recorded November 20th, 2024

In this episode of NETCAST, leading neuroendocrine experts Dr. Mohammed and Dr. Chauhan meet with Dr. Gangi to discuss their recent studies on innovative therapies for neuroendocrine tumors. Dr. Chauhan presents findings on Peltocetine, a new oral somatostatin receptor agonist, highlighting its efficacy in treating carcinoid syndrome. Dr. Mohammed shares insights on NP101, a combination therapy for metastatic neuroendocrine carcinomas, emphasizing its potential in enhancing treatment outcomes. The conversation explores the future of neuroendocrine cancer treatment, focusing on patient preferences and the importance of ongoing research. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.